NCT06712706
Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 5 words
- Trial completed
- Site details revised
Minor Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
- Enrollment target: estimated 70 to confirmed 60
- Primary completion date changed from estimate of Dec 31, 2024 to Jan 31, 2025
- Study completion date: Jan 31, 2025 to Jun 30, 2026
- Site details revised
- Notable Eligibility criteria revised
- Secondary endpoints: details revised at 2 of 2 entries
- Study description shortened, about 11 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
Included are: * Adult patients aged 18 years and above at the time of diagnosis. * Advanced-stage esophageal cancer or cancer of the esophageal junction and treated with curative intent, including neoadjuvant treatment. * Patients who received an FJT before neoadjuvant treatment or during definitive surgery. * Patients treated between 2017 and 2024 in the single institution of the City Hospital Zürich Triemli and completed 6 months of follow-up or died by 31.12.2024. Patients receiving the FJT at staging laparoscopy will be compared to patients receiving FJT at the time of esophagectomy.
Procedures: Feeding jejunostomy placement, Feeding jejunostomy placement at esophagectomy
Sites
1 site in 1 country
- Stadtspital ZürichZurich, Canton of Zurich, Switzerland